Pricing Log in Create free account

Galecto, Inc. (DMRA) vs Korsana Biosciences, Inc. (KRSA)

Galecto, Inc. and Korsana Biosciences, Inc. are both Biotechnology companies. Galecto, Inc. and Korsana Biosciences, Inc. are of similar size ($1.4B and $1.4B). Korsana Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Galecto, Inc. trades at 24.7×. Across the 10 metrics below, Galecto, Inc. leads on 6 and Korsana Biosciences, Inc. on 4.

Valuation

Metric DMRA KRSA Biotechnology median
P/E 24.65 n/m 10.60
P/S n/m 9.01 9.40
P/B 4.00 3.67 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 8.34 9.02
Earnings yield 4.06% (38.12%) (32.88%)
Free cash flow yield (4.05%) (24.20%) (23.13%)

Profitability

Metric DMRA KRSA Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (39.51%) (98.22%) (51.96%)
Return on assets (27.08%) (82.29%) (46.06%)
Return on invested capital 0.00% (115.40%) 0.00%

Growth

Metric DMRA KRSA Biotechnology median
Revenue growth (TTM) — (28.83%) 6.76%
EPS growth (last fiscal year) (730.84%) 8.26% 29.88%
Revenue growth, 5-year CAGR — (14.38%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DMRA KRSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.80 0.82 4.97
Net debt to EBITDA 1.22 0.65 1.01

Dividend

Metric DMRA KRSA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DMRA KRSA Biotechnology median
Market cap 1.35b 1.39b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack